Most Recent
A Larrakia Danggalaba man has sought access to documents for a possible lawsuit over the federal government's decision to greenlight the destruction of an Aboriginal cultural site to develop Defence housing.
A judge has ordered Crown Resorts to share the costs of soft class closure with the plaintiff in a shareholder class action accusing it of lax anti-money laundering compliance, saying that soft class closure ahead of mediation was in the interests of both parties.
A class action over the Victorian government’s decision to retire Melbourne’s high rise public housing towers has agreed to drop claims against the state of Victoria and the minister for housing after a judge threw out the claims but allowed the class action to replead.
A solicitor has lost her bid to appeal a decision which found Legal Aid NSW did not discriminate against her by declining to offer her a new temporary employment contract while she was on pregnancy-related leave.
A Melbourne sex worker has discontinued his discrimination claim against two financial service providers that denied him an EFTPOS machine, on the proviso that the companies will not refuse services to customers engaged in lawful sex work.
McDonald’s has hit back at a class action over alleged unpaid work done by managers before and after shifts, saying it paid more than the minimum entitlements and is entitled to set off those payments against claims for compensation.
Approving a settlement between insurers and group members in an investor class action against lender Axsesstoday, a judge has aired his frustration with expansive confidentiality provisions and deeds that “misapprehend the nature of the court’s role” in dealing with group members’ claims.
A judge has approved a $25 million settlement in a class action against a group of surgeons who worked for the Cosmetic Institute, including a $8.9 million payout for the lawyers that ran the seven-year-old case, saying the deduction from the settlement was reasonable given the "very significant discount" applied to the legal bill.
ASIC has argued a recent ruling that found Noumi waived privilege over a PwC report by providing it to the regulator could dissuade people from voluntarily disclosing information during investigations and cause a “loss of public benefit” if allowed to stand.
Otsuka Pharmaceutical has hit back at suit filed by Indian generics company Sun Pharma seeking to invalidate its patent for blockbuster antipsychotic Abilify, filing a cross-claim seeking to restrain Sun Pharma from infringing the patent with a generic version of the drug.